Molecular targeted therapy of
BRAF inhibitors
BRAF mutation
chemotherapy
colorectal cancer
Journal
Therapeutic advances in medical oncology
ISSN: 1758-8340
Titre abrégé: Ther Adv Med Oncol
Pays: England
ID NLM: 101510808
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
01
2019
accepted:
16
05
2019
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
28
6
2019
Statut:
epublish
Résumé
Over the past two decades, the molecular characterization of metastatic colorectal cancer (mCRC) has been revolutionized by the routine implementation of
Identifiants
pubmed: 31244912
doi: 10.1177/1758835919856494
pii: 10.1177_1758835919856494
pmc: PMC6582307
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1758835919856494Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declare the following conflicts of interest: MD: Personal fees: MSD, Merck Serono, Roche, Bayer, Ipsen, Lilly, Servier, AMGEN, HalioDX, Sanofi; Travel, accommodation, expenses: Roche, MSD, AMGEN. AC: Personal fees: AMGEN PLP: Travel accommodation, expenses: Roche, MSD. CS: None. AEH: Personal fees: Merck Serono, AMGEN, Gribstone Oncology; Travel, accommodation, expenses: AMGEN, SERVIER. PD: None. ES: Personal fees: Sanofi, Bayer, Servier, Pfizer, Novartis, Roche, AMGEN, Merck. VB: Personal fees: Bayer, Merck Serono, Roche, Sanofi, Ipsen; Travel, accommodation: Bayer, Merck Serono, Roche. DM: Personal fees: AMGEN, Bayer, Merck, Merck Serono, Roche, Sanofi, Servier, Shire, HalioDx, Agios. Nonfinancial support: AMGEN, Bayer, Merck, Merck Serono, Roche, Sanofi, Servier. MG: None.
Références
J Cancer. 2013;4(4):320-2
pubmed: 23569465
Cancer Manag Res. 2018 Aug 01;10:2289-2301
pubmed: 30122982
Ann Surg. 2020 Jan;271(1):147-154
pubmed: 29995686
J Clin Oncol. 2011 May 20;29(15):2011-9
pubmed: 21502544
Clin Cancer Res. 2018 Mar 1;24(5):989-990
pubmed: 29269378
Cancer Discov. 2012 Mar;2(3):227-35
pubmed: 22448344
Eur J Cancer. 2014 Jan;50(1):57-63
pubmed: 24138831
J Clin Oncol. 2009 Dec 10;27(35):5931-7
pubmed: 19884549
J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22
pubmed: 20587792
Neoplasia. 2009 Nov;11(11):1116-31
pubmed: 19881948
J Clin Oncol. 2007 May 1;25(13):1670-6
pubmed: 17470860
J Clin Oncol. 2008 Dec 10;26(35):5705-12
pubmed: 19001320
N Engl J Med. 2010 Aug 26;363(9):809-19
pubmed: 20818844
Br J Cancer. 2016 Jan 12;114(1):30-6
pubmed: 26575603
J Clin Oncol. 2017 Aug 10;35(23):2624-2630
pubmed: 28486044
J Clin Oncol. 2012 Jul 1;30(19):2375-83
pubmed: 22614973
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
J Natl Cancer Inst. 2006 Dec 6;98(23):1731-8
pubmed: 17148775
Lancet Oncol. 2010 Aug;11(8):753-62
pubmed: 20619739
N Engl J Med. 2004 Jun 3;350(23):2335-42
pubmed: 15175435
Ann Oncol. 2015 Oct;26(10):2092-7
pubmed: 26153495
J Natl Cancer Inst. 2013 Aug 7;105(15):1151-6
pubmed: 23878352
Ann Oncol. 2018 Jan 1;29(1):44-70
pubmed: 29155929
J Natl Cancer Inst. 2013 Aug 7;105(15):1075-7
pubmed: 23878351
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369
pubmed: 29632055
Ann Oncol. 2014 Jan;25(1):107-16
pubmed: 24356622
Clin Cancer Res. 2017 Jan 1;23(1):104-115
pubmed: 27354468
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Eur J Cancer. 2017 Jul;79:50-60
pubmed: 28463756
Clin Ther. 2010 Mar;32(3):437-53
pubmed: 20399983
Lancet. 2015 Aug 1;386(9992):444-51
pubmed: 26037941
Cell Biol Toxicol. 1999;15(6):389-94
pubmed: 10811534
Ann Oncol. 2017 Mar 1;28(3):562-568
pubmed: 27993800
Eur J Cancer. 2015 Mar;51(5):587-94
pubmed: 25673558
Ann Oncol. 2017 Sep 01;28(9):2149-2159
pubmed: 28911069
J Clin Oncol. 2012 Apr 20;30(12):1288-95
pubmed: 22393095
Nature. 2012 Jan 26;483(7387):100-3
pubmed: 22281684
Cancer Discov. 2016 Dec;6(12):1352-1365
pubmed: 27729313
Histopathology. 2007 Jan;50(1):113-30
pubmed: 17204026
Cancer Discov. 2018 Apr;8(4):428-443
pubmed: 29431699
J Clin Oncol. 2015 Dec 1;33(34):4032-8
pubmed: 26460303
Cancer Res. 2017 Dec 1;77(23):6513-6523
pubmed: 28951457
Cancer. 2011 Oct 15;117(20):4623-32
pubmed: 21456008
Lancet Oncol. 2015 Oct;16(13):1306-15
pubmed: 26338525
Gut. 2013 Apr;62(4):540-9
pubmed: 22798500
Clin Cancer Res. 2015 Mar 15;21(6):1313-20
pubmed: 25589621
J Clin Oncol. 2021 Feb 1;39(4):285-294
pubmed: 33356422
Clin Cancer Res. 2017 Sep 15;23(18):5339-5348
pubmed: 28611198
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Ann Oncol. 2018 May 1;29(5):1227-1234
pubmed: 29518181
Oncogene. 2007 May 14;26(22):3279-90
pubmed: 17496922
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Clin Colorectal Cancer. 2018 Mar;17(1):73-79
pubmed: 29128266
J Clin Oncol. 2018 Mar 10;36(8):773-779
pubmed: 29355075
Mol Oncol. 2016 Jan;10(1):157-65
pubmed: 26440707
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Eur J Cancer. 2017 Mar;73:74-84
pubmed: 27986363
Cancer. 2014 Aug 1;120(15):2316-24
pubmed: 24737664
Ann Oncol. 2013 Mar;24(3):742-8
pubmed: 23131393
Clin Cancer Res. 2014 Mar 1;20(5):1074-80
pubmed: 24352648
Cancer Discov. 2016 Mar;6(3):300-15
pubmed: 26732095
Oncologist. 2017 Jul;22(7):823-833
pubmed: 28526719
J Clin Oncol. 2012 Oct 1;30(28):3499-506
pubmed: 22949147
J Clin Oncol. 2012 Jan 20;30(3):316-21
pubmed: 22067401
J Natl Cancer Inst. 2014 Jun 12;106(7):
pubmed: 24925349
Curr Cancer Drug Targets. 2012 Sep;12(7):873-98
pubmed: 22515520
Br J Cancer. 2014 Mar 4;110(5):1148-54
pubmed: 24407191
Br J Cancer. 2017 Jul 11;117(2):203-209
pubmed: 28595259
PLoS One. 2015 Jun 29;10(6):e0131046
pubmed: 26121270
Lancet Oncol. 2017 Sep;18(9):1182-1191
pubmed: 28734759
Cell. 2016 Apr 7;165(2):317-30
pubmed: 27058664
J Clin Oncol. 2015 Dec 1;33(34):4023-31
pubmed: 26392102
Eur J Cancer. 2012 Jul;48(10):1466-75
pubmed: 22446022
Lancet Oncol. 2010 Sep;11(9):845-52
pubmed: 20702138
N Engl J Med. 2014 Oct 23;371(17):1609-18
pubmed: 25337750
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):191-5
pubmed: 14734469
Br J Cancer. 2015 Jun 9;112(12):1966-75
pubmed: 25973534
Br J Cancer. 2015 Jun 9;112(12):1921-8
pubmed: 25942399
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
JAMA Surg. 2018 Jul 18;153(7):e180996
pubmed: 29799910
Oncotarget. 2017 Feb 7;8(6):9251-9266
pubmed: 27999210
Clin Cancer Res. 2015 Dec 1;21(23):5215-21
pubmed: 26202952
Lancet Oncol. 2014 Mar;15(3):323-32
pubmed: 24508103
N Engl J Med. 2014 Nov 13;371(20):1867-76
pubmed: 25265494
J Natl Cancer Inst. 2005 Jul 6;97(13):981-9
pubmed: 15998951
Ann Oncol. 2017 May 1;28(5):1023-1031
pubmed: 28453697
Br J Cancer. 2015 Jun 9;112(12):1888-94
pubmed: 25989278
Nature. 2017 Aug 10;548(7666):234-238
pubmed: 28783719
ESMO Open. 2017 Aug 10;2(3):e000241
pubmed: 29209533
Cancer Discov. 2017 Jun;7(6):610-619
pubmed: 28363909